Top Page
Hiscox
(LSE:HSX)
Hiscox (HSX) vs. iShares MSCI United Kingdom ETF (EWC)
Hiscox Business Overview & Revenue Model
Hiscox Earnings Call Summary
Hiscox Financial Statement Overview
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.48B | 3.81B | 3.70B | 2.98B | 3.29B |
| Gross Profit | 5.48B | 3.81B | 3.58B | 2.98B | 3.29B |
| EBITDA | 883.45M | 799.20M | 730.00M | 335.60M | 248.20M |
| Net Income | 616.77M | 627.20M | 712.00M | 253.90M | 189.50M |
Balance Sheet | |||||
| Total Assets | 12.19B | 11.24B | 11.06B | 13.72B | 13.85B |
| Cash, Cash Equivalents and Short-Term Investments | 878.32M | 1.23B | 1.47B | 1.40B | 1.35B |
| Total Debt | 832.60M | 743.00M | 754.20M | 635.90M | 746.50M |
| Total Liabilities | 8.24B | 7.55B | 7.76B | 11.31B | 11.31B |
| Stockholders Equity | 3.95B | 3.69B | 3.30B | 2.42B | 2.54B |
Cash Flow | |||||
| Free Cash Flow | 73.00M | 75.30M | 188.40M | 352.50M | -42.30M |
| Operating Cash Flow | 74.33M | 114.40M | 232.10M | 373.40M | 16.60M |
| Investing Cash Flow | -115.78M | -38.50M | -34.20M | -81.90M | -36.60M |
| Financing Cash Flow | -364.69M | -282.60M | -128.90M | -190.90M | -246.20M |
Hiscox Technical Analysis
Hiscox Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | £7.46B | 10.59 | 22.59% | 2.99% | 6.00% | -24.29% | |
76 Outperform | £1.63B | 9.09 | 15.18% | 11.03% | 8.78% | -38.83% | |
75 Outperform | £334.67M | 8.55 | 16.39% | 4.89% | 7.77% | 35.65% | |
74 Outperform | £5.01B | 11.29 | 16.60% | 1.93% | 1.12% | -18.14% | |
74 Outperform | £9.08B | 10.98 | 65.36% | 7.42% | 22.62% | 106.27% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | £780.69M | -20.50 | -76.14% | ― | -35.05% | 74.73% |
Hiscox Corporate Events
Hiscox has continued its recently announced share buyback programme with the repurchase of 51,029 ordinary shares on 25 February 2026 via Peel Hunt at a volume-weighted average price of 1,524.13 pence. The shares, all bought on the London Stock Exchange within a price range of 1,497.00p to 1,531.00p, will be cancelled, marginally reducing the company’s share count and reflecting ongoing capital management efforts that can be supportive for earnings per share and existing investors.
The transaction details were disclosed in line with UK Market Abuse Regulation requirements, including aggregated venue data and a full schedule of individual trades executed throughout the trading day. By providing granular transparency on each buyback trade, Hiscox underscores regulatory compliance and signals disciplined execution of its authorised repurchase plan, which may be closely watched by equity markets and governance-focused stakeholders.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1710.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox has launched a new share repurchase programme of up to $300 million, beginning with a $150 million tranche to be completed by the end of the third quarter of 2026, as it returns surplus capital to investors and cancels the shares bought back. The company has mandated Peel Hunt to execute the initial tranche on the open market under strict UK regulatory parameters, with a maximum of 20,776,059 ordinary shares eligible for repurchase and no assurance the full programme will be completed.
Chief executive Aki Hussain framed the buyback as the third in three years and part of a broader capital return exceeding $1.1 billion, supported by strong 2025 results, a 20% rise in the final dividend for a second consecutive year, and progress in retail growth, technology investment and big-ticket initiatives. Management argues that Hiscox’s diversified specialty portfolio and ongoing change programme leave it well positioned to capture growth opportunities while continuing to enhance shareholder returns.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1639.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox reported a third consecutive year of record results for 2025, with insurance contract written premiums up 5.9% to $4.98 billion and profit before tax rising to $732.7 million. The group posted its best combined ratio in a decade at 87.8%, record underwriting and investment income, and strong capital generation supporting a 20% increase in the final dividend and a new $300 million share buyback, bringing announced capital returns over three years to more than $1.1 billion.
Retail premiums grew 6.3% in constant currency as Hiscox expanded into adjacent specialist segments, entered Italy through a bolt-on broker acquisition and accelerated product launches, particularly in emerging professions and technology-focused lines. Management said its multi-year change programme delivered a $29 million profit benefit in 2025 and remains on track to deliver $200 million annually from 2028, reinforcing ambitions for faster retail growth and cementing the company’s positioning as a diversified, pure-play specialty insurer.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1639.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced that, as of 30 January 2026, its issued ordinary share capital consists of 332,380,013 ordinary shares of 6.5p each, of which 7,523,190 are held in treasury and carry no voting rights. As a result, the total number of voting rights in the company stands at 324,856,823, a figure that shareholders must use as the reference denominator when assessing and disclosing any changes in their shareholdings under applicable transparency rules.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1638.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has reported that as of 31 December 2025 its issued ordinary share capital comprised 332,375,257 ordinary shares of 6.5p each, of which 7,523,190 are held in treasury. After excluding treasury shares, the company confirmed that the total number of voting rights stands at 324,852,067, a key reference figure shareholders must use when assessing whether they are required to disclose holdings or changes in their interests under applicable transparency rules.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has continued to execute its previously announced share buyback programme, repurchasing 99,191 ordinary shares on 19 December 2025 through Citigroup Global Markets at a volume-weighted average price of 1,428.42 pence. The shares, acquired solely on the London Stock Exchange within a narrow intraday price range of 1,422–1,431 pence, will be cancelled, modestly reducing the company’s share capital and enhancing capital return to shareholders as part of its ongoing capital management strategy.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox has completed its previously announced share repurchase programme, buying back a total of 15,894,323 ordinary shares for $275 million between 27 February and 19 December 2025. The programme, executed in two tranches through Peel Hunt and Citigroup, was initially set at $175 million and later increased to $275 million, signalling management’s confidence in the group’s capital position and long‑term prospects while returning substantial capital to shareholders.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox has continued to execute its previously announced share buyback programme, repurchasing 190,000 ordinary shares on 18 December 2025 via Citigroup Global Markets at a volume-weighted average price of 1,417.22 pence, within a range of 1,413.00 to 1,421.00 pence. The company will cancel the repurchased shares, modestly reducing its share count and potentially enhancing earnings per share, underscoring ongoing capital management efforts and signalling confidence in its balance sheet and long-term prospects for shareholders.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 161,200 of its Ordinary Shares at an average price of 1,416.78 GBp on December 17, 2025. This move demonstrates the company’s commitment to optimizing shareholder value, and the purchased shares will be canceled, potentially signaling confidence in its financial position and strategy.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 160,762 of its own ordinary shares through Citigroup Global Markets Limited. The buyback, part of a previously announced program, aims to enhance shareholder value by reducing the number of shares in circulation, potentially increasing earnings per share and signaling confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 161,200 of its own ordinary shares as part of its share buyback program. The shares were bought at prices ranging from 1,359.00 GBp to 1,390.00 GBp and will be cancelled, indicating a strategic move to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its ongoing share buyback program. This strategic move, executed through Citigroup Global Markets Limited, is aimed at enhancing shareholder value by reducing the number of shares in circulation, potentially increasing the value of remaining shares and demonstrating confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of a share buyback program. This move, executed through Citigroup Global Markets Limited, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd, a company engaged in a share buyback programme, announced the purchase of 169,917 ordinary shares at a volume weighted average price of 1,314.77 GBp per share. This transaction, executed through Citigroup Global Markets Limited, is part of their ongoing strategy to manage capital and potentially enhance shareholder value by reducing the number of outstanding shares. The purchased shares will be cancelled, which may impact the company’s earnings per share positively and reflect a commitment to returning value to shareholders.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 ordinary shares as part of its ongoing share buyback program. The shares were acquired at a volume-weighted average price of 1,320.05 GBp and will be cancelled. This move is part of Hiscox’s strategy to enhance shareholder value and optimize its capital structure, reflecting confidence in its financial stability and future prospects.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced transactions involving its Chief Financial Officer, Paul Cooper, and Chief Underwriting Officer, Joanne Musselle, under the Hiscox UK Sharesave Plan. Paul Cooper acquired 2,452 shares, while Joanne Musselle acquired 2,380 shares and further subscribed to additional shares through the company’s scrip dividend alternative. These transactions reflect the company’s ongoing commitment to employee investment and engagement, potentially enhancing stakeholder confidence in its leadership and strategic direction.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 ordinary shares as part of its share buyback program, with the highest price paid per share being 1,321 GBp and the lowest at 1,306 GBp. This move is part of the company’s strategy to enhance shareholder value and optimize its capital structure, potentially impacting its market positioning by signaling confidence in its financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1600.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd, a company engaged in the insurance industry, announced a transaction involving the repurchase of 170,000 of its own ordinary shares as part of its ongoing share buyback program. The shares were purchased at prices ranging from 1,307.00 GBp to 1,322.00 GBp, with a volume-weighted average price of 1,316.45 GBp. This move is part of Hiscox’s strategy to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £1453.00 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 169,810 of its own ordinary shares at prices ranging from 1,307.00 GBp to 1,325.00 GBp, with a volume-weighted average price of 1,319.76 GBp. The repurchased shares will be canceled, which is expected to enhance shareholder value by reducing the number of shares outstanding, potentially increasing earnings per share and signaling confidence in the company’s financial health.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the purchase of 170,000 of its own ordinary shares as part of its share buyback program, with the highest price paid per share being 1,323 GBp and the lowest 1,301 GBp. This strategic move to repurchase shares is likely aimed at enhancing shareholder value and optimizing the company’s capital structure, reflecting positively on its market confidence and potentially impacting its stock performance.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 ordinary shares at prices ranging from 1,313.00 GBp to 1,326.00 GBp, with an average price of 1,319.27 GBp. This move is part of a strategic initiative to optimize the company’s capital structure and enhance shareholder value, reflecting confidence in its financial health and future prospects.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 of its own ordinary shares through Citigroup Global Markets Limited. The shares were bought at prices ranging from 1,326.00 GBp to 1,337.00 GBp, with a volume-weighted average price of 1,331.11 GBp. This move is part of Hiscox’s ongoing strategy to manage its capital structure and enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced its total voting rights as of November 28, 2025, with an issued ordinary share capital of 335,584,387 shares, of which 7,523,190 are held in Treasury and do not carry voting rights. This results in a total of 328,061,197 voting rights, which shareholders can use as a reference for calculating their interests under the Disclosure and Transparency Rules.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has announced the repurchase of 167,862 of its own ordinary shares as part of its ongoing share buyback program. The shares were bought at a volume-weighted average price of 1,341.26 GBp and will be canceled, potentially impacting the company’s share capital structure and signaling confidence in its financial position.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 of its ordinary shares at prices ranging from 1,330.00 GBp to 1,346.00 GBp, with a volume-weighted average price of 1,340.72 GBp. This move is part of the company’s strategy to enhance shareholder value by reducing the number of shares outstanding, which may positively impact its share price and earnings per share.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd announced the purchase of 170,000 ordinary shares as part of its ongoing share buyback program. The shares were acquired at a volume-weighted average price of 1,327.84 pence per share and will be canceled, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.
Hiscox Ltd has executed a share buyback program, purchasing 170,000 of its ordinary shares at prices ranging from 1,295.00 GBp to 1,327.00 GBp. This move is part of a strategic initiative to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (GB:HSX) stock is a Buy with a £15.60 price target. To see the full list of analyst forecasts on Hiscox stock, see the GB:HSX Stock Forecast page.